high pDCs secrete higher levels of IL12p40, express higher levels of costimulatory molecule CD80, and are more efficient in triggering proliferation of naive allogeneic T cells. Thus, human blood pDCs are composed of subsets with specific phenotype and functions.
D endritic cells (DCs)
5 represent a complex system of cells with different anatomical localization, distinct subsets, and distinct functions (1, 2) . Two main DC pathways bearing common and unique functions have been recognized, i.e., myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) (2, 3) . The pDCs have been described independently in the late 1970s as plasmacytoid monocytes and plasmacytoid T cells. In the 1990s, pDCs were identified as DCs (4, 5) and as the natural IFN-producing cells (6 -8) . Indeed, upon viral encounter, pDCs rapidly secrete considerable amounts of type I IFNs (6, 7) as well as numerous chemokines (9) . pDCs can be activated by 1) viruses (6, 7); 2) IL-3 and CD40L (IL-3/CD40L) (5, 10), possibly originating from mast cells triggered for example by parasites; and 3) by bacterial components in the form of CpG DNA (11, 12) . Once activated, pDCs induce the expansion and differentiation of Ag-specific memory B and T lymphocytes, yielding plasma cells (13) and CTLs (14, 15) . There is evidence that pDCs are involved in tolerance induction (16 -18) . pDCs stimulated via TLR or CD40 induce IL-10-secreting regulatory CD4
ϩ T cells owing to the expression of ICOS ligand (19) as well as suppressor CD8
ϩ T cells (20) . Finally, pDCs activated via IL-3/CD40L can also drive type 2 polarization of CD4 ϩ T cells (10) . pDCs play a key role in disease pathogenesis. Their alteration appears central to immune dysfunction underlying systemic lupus erythematosus (SLE), a prototype autoimmune disease characterized by a break of tolerance to self-Ags (21) (22) (23) . pDC accumulate in skin lesions of SLE (24) where they become activated and secrete type I IFN, thereby contributing to tissue damage. Early studies demonstrated that immune complexes are potent stimuli for IFN-␣ secretion by pDCs in a FcR (CD32)-dependent manner (25, 26) . Indeed, chromatin and/or ribonucleoprotein-containing immune complexes can be internalized by pDCs via Fc␥RIIa, reach the endosomal compartment, and activate IFN-␣ secretion through TLR9-and/or TLR7-dependent pathways (27, 28) . Sera from SLE patients can also induce IFN-␣ secretion in a TLR7/8-dependent manner (29) . The aberrantly produced IFNs are major effectors in the pathogenesis of autoimmunity, mainly by inducing an unabated maturation of peripheral mDCs (22) that can stimulate autoreactive T cells. DNA-containing immune complexes can also activate pDCs to produce IFN-␣ via the high mobility group box 1 protein (HMGB1) activation of TLR9 through a mechanism involving the Ig superfamily member RAGE, receptor for HMGB1 (30) . Similar observations were made in psoriasis (31) . There, antimicrobial peptide LL37 (also known as CAMP) has been shown as the key factor that mediates pDC activation (32) . LL37 converts inert self-DNA into a potent trigger of IFN production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger TLR9 (32) . Accumulation of pDCs has also been found in cancer, most particularly in breast cancer, where it has been suggested to represent an independent prognostic factor associated with poor outcomes as measured by overall survival and time to disease progression (33) . Furthermore, in vivo signaling via TLR ligands such as CpG (TLR9) (34) or imiquimod (TLR7) (35) leads to tumor regression both in mice and humans, possibly via mobilization of pDCs. These observations raise a question as to the role of pDCs in tumor microenvironment. The analysis of pDC transcripts revealed several unusual features including the presence of granzyme B (36) , an effector molecule of CTLs and NK cells. We show here that pDCs display cytotoxic properties and are composed of subsets with distinct phenotype and functions.
Materials and Methods

Isolation of DCs
PBMCs were isolated from buffy coats by Ficoll centrifugation. Monocytes, T cells, B cells, and RBC were depleted using respective mAbs coupled to microbeads (CD3, CD14, CD19, and glycophorin A; Miltenyi Biotec). Enriched PBMCs were labeled with CD11c-allophycocyanin, HLA-DR-QR, CD123-PE, and a mixture of FITC-or PE-coupled mAbs against lineage markers: CD3, CD14, CD16, CD19, CD20, CD56 (BD Biosciences). In some experiments, cells were also stained additionally with CD2-PE-Cy7 (39C1.5; Beckman Coulter). Alternatively, pDCs were sorted using a lineage mixture, HLA-DR, BDCA-2 (AC144; Miltenyi Biotec), and CD2 (S5.2; BD Biosciences). Cells were sorted using either FACSVantage or FACSAria (BD Biosciences). NK cells were sorted from nondepleted PBMCs using CD16-FITC and CD56-PE (BD Biosciences).
Cell culture
Cultures were established in endotoxin-free medium consisting of RPMI 1640 supplemented with 10% (v/v) heat-inactivated FCS, 10 mM HEPES, 2 mM L-glutamine, penicillin, and streptomycin. Sorted total pDCs, mDCs, and NK cells were seeded at 5 ϫ 10 5 cells/ml in medium containing 20 ng/ml IL-3 (R&D Systems) and 200 ng/ml CD40L (R&D Systems), 6 g/ml CpG (InvivoGen), or 1 hemagglutination unit/culture well (corresponding to ϳ10 4 viral particles) Influenza A/PR8/34 virus (Charles River Laboratories). Sorted CD2 high and CD2 low pDCs were seeded at 1.25 ϫ 10 5 cells/ml unless otherwise indicated. After 18 -24 h of culture, cells and supernatants were harvested for further analysis.
ELISA
Secretion of granzyme B was determined using either 1) a sandwich ELISA kit (Research Diagnostic) following the manufacturer's protocol or 2) Luminex assay. Secretion of TRAIL was determined using an ELISA kit (Research Diagnostic).
Cytokine multiplex analysis
Cell culture supernatants from activated pDCs were diluted 1/2.5 with culture medium and analyzed using the Beadlyte cytokine assay kit (Millipore) as per the manufacturer's protocol. Assay plates were run on the Bio-Plex Luminex 100 XYP instrument (Bio-Rad) for analysis. Cytokine concentrations were calculated using Bio-Plex Manager 3.0 software with a five-parameter curvefitting algorithm applied for standard curve calculations.
Microarrays
Total RNA was extracted from sorted pDC subsets of two different normal donors. After two rounds of linear amplification, cRNA was hybridized on Affymetrix HG-U133A GeneChip arrays. Specific hybridization intensity, probe set signal values, and present/absent calls were computed using GeneChip Operating Software version 1.0.0.046. Normalization of signal values per chip was achieved using the GeneChip Operating Software version 1.0.0.046 global method of scaling to the target intensity value of 500/GeneChip. Gene expression was analyzed with GeneSpring 7.1 software. Transcripts were ranked based on fold change and absolute difference in expression between the two study conditions. Each probe set was previously normalized with a per chip normalization to the 50th percentile and a per gene normalization to the median of each gene. (This per chip normalization was applied to these data.) GEO accession no. GSE15215; http://www.ncbi.nlm.nih.gov/projects/geo/ query/acc.cgi?acc ϭ GSE15215.
Cr release assay
Harvested total pDCs, mDCs, NK cells, and CD2 high CD2 low pDCs were used as effectors. Effectors were cocultured with 51 Cr-labeled K562 at 100:1 E:T ratio or 30:1 E:T ratio. After 18 h of culture, supernatants were analyzed. Percentage of specific lysis was calculated as (cpm experiment Ϫ cpm spontaneous release )/(cpm maximum release Ϫ cpm spontaneous release ).
Confocal imaging
Five ϫ 10 5 cells were washed twice with ice-cold PBS plus 1% BSA, fixed for 20 min in 4% paraformaldehyde, and permeabilized with PBS/0.05% saponin/1% BSA. Endogenous biotin was blocked using endogenous biotin-blocking reagent (Invitrogen). Cells were then stained with FITCconjugated anti-lysozyme (Research Diagnostic) and either biotin-conjugated anti-BDCA2 (Miltenyi Biotec) or anti-granzyme B (BD Biosciences) followed by treatment with either Alexa Fluor 568-labeled streptavidin or goat anti-mouse IgG2a. respectively (Invitrogen). Washed cells were then mounted onto slides in Vectashield (Vector Laboratories) containing TOPRO-2 (Invitrogen). Cells were then imaged using a Leica TCS-NT/ SP1 confocal microscope equipped with three lasers (argon, krypton, and helium neon) capable of three fluorescence channels and transmitted light detection. Images were acquired on a Leica DMIRBE microscope with the ϫ63 Plan APO objective using Leica TCS version 2.1 software.
Live cell microscopy
Activated CD2 high or CD2 low pDCs were mixed on ice with K562 cells in RPMI 1640 medium with 10% human AB serum at a ratio of 2:1 in flatbottom 48-well plates and allowed to settle on ice for 10 min. Plates were then transferred to a 37°C/5% CO 2 live cell imaging chamber. Cells were imaged either in bright field or 488-nm florescence every 10 s for 8 h using an Olympus IX-70 microscope at ϫ10 magnification (Olympus ϫ10 PlanFl aperture 0.30). Time course images were assembled into stacks using MetaMorph version 6.2r4 (Universal Imaging). For presentation purposes, Quicktime (Apple Computer) movies were generated from assembled stacks. For the purpose of size compression, every tenth frame was inserted into the movie and displayed at a frame rate of 1 frame every 1 ⁄10 s, for a total acceleration of ϳ1600 times. The percentage of pDCs interacting with K562 cells at any given time was determined through an analysis of time-course image stacks. Total cells in the frame at a given time point as well as cells interacting with K562 cells were quantitated using the Manual Object Count Tool in the MetaMorph software package. Frames before and after any given time point were used as a reference to identify cells as they entered clusters. Percent interaction is expressed as the ratio of bond pDCs over the total number of pDCs in the frame for that time point. To monitor tumor cell killing, K562 cells were labeled with calcein-AM (Invitrogen), washed, and cocultured with CD2 high pDCs. Killing was assessed by loss of calcein-AM florescence over time by live cell florescence microscopy.
Electron microscopy
Cells were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.4) for 1 h at room temperature, washed in cacodylate buffer, and postfixed in 1% osmium tetroxide in the same buffer for 1 h at room temperature. Cells were stained en bloc in 2% uranyl acetate in 50 mM sodium maleate (pH 5.2) for 1 h at room temperature, then dehydrated in ethanol and embedded in EMbed 812 epoxy resin (all EM reagents from Electron Microscopy Sciences). Ultrathin sections were cut on a Reichert Ultracut E microtome and collected on formvar-and carbon-coated nickel grids. Sections were stained with 1% lead citrate followed by 2% uranyl acetate and examined in a Tecnai 12 Biotwin electron microscope (FEI). Digital images were recorded using a Morada charge-coupled device camera (Olympus Soft Imaging Solutions).
Thymidine incorporation assay
Harvested total pDCs and mDCs were used as effectors. Effectors were cocultured with K562 cells for 18 h at a ratio of 100:1 E:T ratio. After 18 h, cell were pulsed with 1 Ci/well of 
Statistical analysis
The nonparametric Mann-Whitney U test and paired Wilcoxon test were used as indicated.
Results
Activated blood pDCs display cytotoxic properties
pDCs and mDCs were sorted from PBMCs as LIN neg HLA-DR
Ϫ cells (mDCs) as described earlier (9) . pDCs were analyzed either fresh or after overnight activation with three wellcharacterized activators: IL-3/CD40L, influenza virus (PR8, H1N1), or CpG A. Freshly isolated pDCs, but not mDCs, show transcription of granzyme B consistent with earlier studies (36) at levels similar to those observed in cultured Ag-specific CD8 ϩ T cells (data not shown). However, although CD8 ϩ T cells show transcription of at least four genes coding different types of granzymes (37), pDCs express uniquely granzyme B (data not shown). Resting pDCs express the granzyme B protein (data not shown) and its expression and secretion to culture supernatant is considerably increased after activation (data not shown).
Freshly isolated blood pDCs do not kill efficiently chronic myeloid leukemia-derived K562 cells (data not shown). However, pDCs activated with IL-3/CD40L kill K562 cells as measured by the release of 51 Cr (mean Ϯ SEM ϭ 29 Ϯ 5% specific lysis, range 10 -46%, n ϭ 8; Fig. 1A ). Specific lysis in cocultures of K562 cells with pDCs was significantly higher than that observed with mDCs (mean Ϯ SEM ϭ 7 Ϯ 2.4% specific lysis; range, 0 -17%, p Ͻ 0.005; Fig. 1A ). The killing of K562 cells by pDCs required high E:T ratio (E:T ratio ϭ 100:1) and long E:T interaction (18 h). pDCs also demonstrated cytotoxic function against cancer cells when activated with influenza virus (mean Ϯ SEM ϭ 22.5 Ϯ 2.5% specific lysis, n ϭ 4) or CpG (Fig. 1B) . CpG-activated pDCs were 1D ). These results indicate that activated pDCs can halt the growth of tumor cells in vitro. Although the killing of target cells by pDCs as measured in a chromium release assay appears not very efficient (high E:T ratio and long incubation time), pDCs are able to abrogate tumor cell growth almost completely (Fig. 1D) . These results suggest that pDC might be important in the control of tumor growth.
CD2 distinguishes two fractions of blood pDCs
The killing of K562 by activated pDCs could be blocked by EGTA, indicating Ca 2ϩ dependence (data not shown). Supernatants from activated pDCs or from pDC/K562 cocultures did not kill K562 cells, indicating the cell contact dependence (data not low (left panels) and CD2 high (right panels) pDCs were fixed and processed for transmission electron microscopy. Note the abundance of endoplasmic reticulum in both subsets of cells (arrows). Bar, 2-m. B, CD2 staining in flow cytometry on pDC subsets presort, after sort, and after an 18-h activation with CpG. C, Sorted CD2 low (upper panels) and CD2 high (lower panels) were cultured overnight at 30,000 cells/well with either 1 live hemagglutinin unit/ well PR8 virus or 6 g/ml CpG. Harvested cells were analyzed by flow cytometry for their surface expression of CD2. Upper panels, CD2 low pDC isotype control, CD2 staining after sort, CD2 staining after PR8 exposure, and CD2 staining after CpG exposure. Lower panels, CD2 high pDCs after PR8 exposure. Representative experiment of four performed testing different conditions of pDC activation is shown.
shown). Accordingly, live microscopy demonstrated that activated pDCs form tight clusters with K562 within 45 min of coculture (Fig. 1E) (Fig. 2, A and B) revealed differential expression of CD2 (38 -41) . In PBMC staining, CD2 high pDCs show CD2 staining intensity within the range of that in T cells (Fig. 2A) . Analysis of 14 healthy donors showed that 12-43% of blood pDCs express CD2 at high levels (mean Ϯ SD: 22.5 Ϯ 8.7%; Fig. 2C ). Given that pDCs represent ϳ0.25 Ϯ 0.1% of adult PBMCs, CD2 high pDCs represent ϳ0.05% of mononuclear cells. CD2 high pDCs were also detected in cell suspensions prepared from tonsils as BDCA-2 ϩ CD2 high double-positive cells (mean, 0.77% of cell suspension; range, 0.36 -1.54%; mean, 22.8% of BDCA-2 ϩ pDCs; range, 16.7-32%; Fig. 2D ). Giemsa staining of sorted CD2 high pDCs revealed morphology characteristic of pDCs (data not shown). Similarly, both subsets display pDC ultrastructure in electron microscopy with rich endoplasmic reticulum (Fig. 3A) . Furthermore, after sort and overnight culture with IL-3/CD40L or with CpG A, CpG B, C, or live influenza virus, CD2
high pDCs retain the expression of CD2 while CD2 low pDC do not acquire expression of CD2 (Fig. 3B) , suggesting that CD2 on pDCs is not a mere marker of cell activation. Thus, pDCs can be separated according to CD2 expression, and CD2 high and CD2 low pDCs display comparable morphology and ultrastructure.
CD2 high pDCs express lysozyme
A microarray analysis of sorted CD2 high and CD2 low subsets of pDCs revealed that the most significantly overexpressed transcript in CD2 high pDCs was lysozyme (139-fold overexpression). This is unexpected as lysozyme is known to be a product of myeloid cells such as neutrophils, monocytes as well as epithelial cells and plays a role in the breakdown of bacterial cell walls (42) (Fig. 4A) . Accordingly, CD2
high pDCs exclusively expressed lysozyme in their intracellular compartments (Fig. 4B) , thus confirming the existence of two distinct pDC subsets. However, adding lysozyme to cocultures of CD2 low pDCs and K562 cells was not sufficient to reproduce K562 cell killing (data not shown). Interestingly, cells costaining with anti-BDCA-2 and anti-lysozyme Abs could be observed in biopsies of melanoma tumors from patients (Fig. 4C) . Transcription of several other molecules could distinguish the two subsets (Fig. 4, A and D) . Beside lysozyme, the top five transcripts overexpressed in CD2 high pDCs included Gas7, a member of growth arrest-specific genes expressed in neurons (43) and possibly involved in dendrite formation (44) ; AXL, a member of the Tyro 3 family of receptor tyrosine kinases with anti-inflammatory activities (45) that is involved in type I IFNmediated suppression of TNF production (46); CHST6, a gene encoding an enzyme carbohydrate sulfotransferase (47) ; and RGC32, a member of response genes to complement (48), whose expression was found up-regulated in blood cells of patients with hyper-IgE syndrome (49) (Fig. 4A) . The transcription pattern of CD2 low pDCs was strikingly different and the most overexpressed transcript NSEP1 encodes YB-1 (50), a transcription factor involved in the regulation of the cell cycle (50) as well as in biological effects of IFN-␥ (51, 52). Interestingly, YB-1 protein appears to interact with different viruses including HIV (53, 54) . Other molecules implicated in cell cycle regulation were also transcribed by CD2 low pDCs including CDKN2D, an inhibitor of cyclin-dependent kinases (55) and CCNL2, cyclin L2 (56). Finally, the top transcripts also encompassed molecules relevant for endoplasmic reticulum such as COPE (57) (Fig. 4D) and RRBP1 ribosome-binding protein (58) (data not shown).
Thus, pDC subsets distinguished by CD2 display distinct and unique transcription and protein expression profiles.
Activated CD2 high pDCs form tight clusters with other cells
Both pDC subsets responded to activation via CD40 with increased transcription and expression of granzyme B and TRAIL (data not shown). Cell tracking in live microscopy indicated that, after 1 h, ϳ30% of CD2 high pDCs, but Ͻ10% of CD2 low pDCs, were capable of interacting with K562 cells (Fig. 5A , movie Fig. S1 6 ). After 8 h of observation, up to 80% of CD2 high pDCs were interacting with K562 cells when Ͻ20% of CD2 low pDCs interacted with K562 (Fig. 5A) . The interactions between CD2 high pDCs and K562 cells involved several pDCs bound to a K562 target cell (Fig. 5B) and lead in many instances to K562 cell death (movie Fig. S2 ). The formation of very tight clusters with other cells might permit pDCs to "screen" their surface and may serve as means to eliminate cells and/or capture Ags for example through nibbling (59) as it has been described for mDCs. Thus, CD2
high pDCs could represent a link between the innate and the adaptive immunity in the context of cancer.
Activated CD2 high pDCs induce proliferation of naive allogeneic T cells
We next analyzed the capacity of CD2 high and CD2 low pDCs to present Ag to T cells. CD2 high and CD2 low pDCs were pulsed with 6 The online version of this article contains supplemental material. influenza virus and cocultured for 6 days with CFSE-labeled autologous CD4 ϩ and CD8 ϩ T cells. As shown in Fig. 6A , both subsets were able to trigger proliferation of autologous T cells to influenza virus. To determine their capacity to launch primary immune responses, pDC subsets were activated with CpG and used in standard MLR. As shown in Fig. 6B, CD2 high pDCs were more efficient than CD2 low pDCs in the induction of naive allogeneic T cell proliferation as measured by thymidine incorporation. These data were further confirmed by the analysis of T cell division by CFSE dilution (Fig. 6C) . The superiority of CD2 high pDCs in stimulating MLR was observed with purified CD4 ϩ T cells (mean Ϯ SEM ϭ 18 Ϯ 3.5% vs 1.6 Ϯ 0.6% for CD2 high and CD2 low pDCs, respectively, p ϭ 0.02; Fig. 6D ) and with CD8 ϩ T cells (mean Ϯ SEM ϭ 4 Ϯ 0.6% vs 0.3 Ϯ 0.1% for CD2 high and CD2 low pDCs, respectively, p ϭ 0.009; Fig. 6D ). However, despite their lower proliferation rate, on a per cell basis, T cells exposed to CD2 low pDCs produced equivalent levels of IL-2, IL-10, and IFN-␥ as those exposed to CD2 high pDCs (Fig. 6E ). Upon challenge with live Influenza virus or CpG, CD2 high pDCs and CD2 low pDCs secreted comparable amounts of IFN-␣, IP-10, and MIP1-␣ (Fig. 7A and data not shown) . Interestingly, CD2 high pDCs activated with live influenza virus secreted higher levels of IL12p40 than CD2 low pDCs isolated from the same donor (Fig.  7B) . A similar difference in IL12 p40 secretion could be observed after activation with CpG (data not shown). Flow cytometry analysis demonstrated the same levels of MHC class I or MHC class II molecule expression by the two pDC subsets (Fig. 7C) . Both subsets also express CD83 typically found on mature DCs (data not shown). Analysis of costimulatory molecules expression showed that CD2 high pDCs can up-regulate CD80 after activation with CpG while CD2 low pDCs do so poorly (Fig. 7D) .
Expression of CD86 is more variable and both subsets can upregulate CD86 although CD2 high pDCs show higher intensity of staining (Fig. 7E) .
Thus, upon activation, pDC subsets defined by high expression of CD2 secrete higher levels of IL12 p40 and show higher expression of CD80 and a distinct capacity to trigger naive T cell expansion.
Discussion
The present study demonstrates that human pDCs are composed of two subsets, which can be distinguished by the expression of CD2. These two subsets are found not only in blood but also in tonsils. In addition to their circulation in the blood and secondary lymphoid organs such as tonsils, CD2
high pDCs can be detected in some tumor biopsies, suggesting their potential involvement in tumor immunosurveillance. Both subsets secrete IFN-␣ and express the cytotoxic molecules granzyme B and TRAIL. The CD2 high pDCs are potent in initiating T cell immune responses. In contrast, the CD2 low pDCs appear to display a limited capacity to induce allogeneic T cell proliferation. These different functional properties of CD2 high pDCs and CD2 low pDCs are associated with distinct transcription profiles, differential secretion of IL12p40, and differential expression of costimulatory molecule CD80 on activation.
In concordance with other studies, granzyme B inhibitor does not seem to affect cytotoxic function of pDCs. Granzyme B-mediated killing of target cells seems to be completely dependent on the presence of perforin (60 -62) , although an alternative mechanism has been suggested (63) . Because pDCs do not express perforin, they must either use another protein that can substitute or they use granzyme for biological function other than killing. Certain acute viral (HIV, EBV) infections seem associated with elevated plasma levels of granzymes A and B (64) . Although it was considered to be associated with an ongoing CTL activation (64) , the source of extracellular granzyme B in these patients may need to be revisited in the view of our results. Furthermore, elevated granzyme B plasma levels were also observed in patients with parasite infection with Plasmodium falciparum (65) and in severe bacterial infection (66) . These in vivo observations are consistent with high secretion triggered in vitro by pDC activation via CD40 and TLR ligands, respectively. Recent studies demonstrate the involvement of granzyme B in extracellular matrix remodeling via cleavage of vitronectin, laminin, and fibronectin (67) . That may lead in vitro to anoikis, cell death due to lack of extracellular contact (67) . This, along with their capacity to secrete granzyme B, could point to a novel role of pDCs in inflammation as well as tumor development and progression.
Thus, the killing mechanism remains to be established. Three recent studies in the human and in the mouse suggested a role of TRAIL-mediated cytotoxicity exerted by cells with pDC properties (68 -70) . Our preliminary results corroborate the potential role of TRAIL (data not shown); however, the inhibition is not complete, suggesting contribution of other mechanisms. The killing is unlikely to be due to contaminating NK cells since it requires a high E:T target ratio and is slow (NK cell-mediated lysis usually occurs at 4 h). We did not detect IFN-␥ transcription or secretion as well as we did not detect perforin (data not shown).
Resting CD2 high pDCs highly transcribe genes involved in the immune functions such as lysozyme, AXL, or fractalkine receptor. Another feature is the expression of two genes linked to Th2 polarization (ALOX5) and Th2 signature such as IgE (RGC32). Thus, CD2 high pDCs might be responsible for the capacity of pDCs to induce type 2 immunity (10). Conversely, CD2 low pDCs highly transcribe genes involved in cell cycle regulation and in secretory functions. Nonactivated CD2 high pDCs also show 2-fold higher transcription of CD2 as compared with nonactivated CD2 low pDC (supplemental Fig. 3 ). Whereas upon activation both subsets express MHC class molecules and CD83, CD2 high pDCs up-regulate CD80. Although both subsets secrete similar levels of cytokines and chemokines such as IL-6, IL-8, TNF ␣, IFN ␣, IP-10, MIP1-␣, and MIP1-␤ on activation, CD2 high pDCs secrete IL12p40. Preliminary results show 2-fold enhanced transcription of p19 in microarrays of activated CD2 high pDCs (data not shown). Thus, the identification of common and unique transcripts further supports the notion of two pDC subsets in humans.
The differential expression of lymphoid-related genes (RAG1 and Ig rearrangement products) (71) or proteins (CD4) (72) and Ly49Q (73) has been used to demonstrate the existence of murine pDC subsets. Similar to our results in humans, murine pDC subsets differ in their capacity to trigger allogeneic T cell proliferation and to secrete IL12p70 and IFN-␥ (71) .
pDCs have been shown to arise from both myeloid and lymphoid-committed hematopoietic progenitor cells (74, 75) . The CD2 subset clearly demonstrates the prevalent expression of myeloid-related genes, thus suggesting that pDCs originating from committed myeloid progenitors might have distinct functions than those originating from committed lymphoid progenitors. Thus, both in humans and mice, pDCs constitute a heterogeneous population of cells which display a remarkable array of immune functions. The existence of two pDC subsets might provide a framework for explanation of a diverse array of immune responses elicited by pDCs ranging from CD8 ϩ T cell tolerance/anergy, generation of regulatory T cells, to Th2 polarization.
